Related Content
September 30, 2013—A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per ...
September 30, 2013
September 4, 2013 — C. R. Bard Inc. has entered into a definitive merger agreement to acquire Rochester Medical Corp. at ...
September 04, 2013
June 10, 2013 — C. R. Bard Inc. announced the enrollment of the first patient into the Lutonix Below the Knee (BTK) ...
June 10, 2013
March 26, 2013 — According to two different reports from Millennium Research Group (MRG), the overall European market ...
March 26, 2013
July 27, 2012 — C. R. Bard Inc. announced that its Lutonix technology center has completed patient enrollment into its ...
July 27, 2012
February 19, 2009 - C. R. Bard Inc. this week said it received pre-market approval (PMA) from the FDA to market the ...
February 19, 2009December 22, 2008 - C. R. Bard Inc. recently received FDA clearance to market the E-Luminexx Vascular Stent - a flexible ...
December 21, 2008October 30, 2008 - C. R. Bard Inc. today received approval from the FDA to market the Flair Endovascular Stent Graft ...
October 29, 2008August 18, 2008 – Maximus, a business unit of infusion therapy firm Medegen Inc., today announced as a result of a co ...
August 17, 2008
The FLAIR Endovascular Stent Graft treats stenoses (narrowing) at the venous anastomosis of synthetic arteriovenous (AV) ...
October 16, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now